德镁医药递交招股书:2024年收入超6亿元 新增制造商生产喜辽妥

中新经纬
May 14, 2025

中新经纬5月14日电 (王玉玲)又一家港股医药公司意欲分拆子公司上市。近日,德镁医药递表港交所。港股上市医药企业康哲药业控股有限公司(CMS,下称康哲药业)4月22日公告称,建议将该公司附属公司德镁医药股份分拆上市。康哲药业为什么要分拆德镁医药,德镁医药又有哪些值得关注的管线?德镁医药仍处于亏损中公开资料显示,康哲药业是综合性医药平台企业,早期以药品代理销售(CSO)为主,后逐步转型覆盖研发、生产...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10